CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression

AIDS ◽  
2001 ◽  
Vol 15 (13) ◽  
pp. 1627-1634 ◽  
Author(s):  
Jacques Reynes ◽  
Pierre Portales ◽  
Michel Segondy ◽  
Vincent Baillat ◽  
Pascal André ◽  
...  
2003 ◽  
Vol 34 (1) ◽  
pp. 114-116 ◽  
Author(s):  
Jacques Reynes ◽  
Vincent Baillat ◽  
Pierre Portales ◽  
Jacques Clot ◽  
Pierre Corbeau
Keyword(s):  
T Cell ◽  

2021 ◽  
Author(s):  
Mitchell J. Mumby ◽  
Aaron L. Johnson ◽  
Steven M. Trothen ◽  
Cassandra R. Edgar ◽  
Richard Gibson ◽  
...  

Serine Incorporator 5 (SERINC5) reduces the infectivity of progeny HIV-1 virions by incorporating into the outer host-derived viral membrane during egress. To counter SERINC5, the HIV-1 accessory protein Nef triggers SERINC5 internalization by engaging the Adaptor Protein 2 (AP-2) complex using the [D/E]xxxL[L/I] 167 Nef dileucine motif. Nef also engages AP-2 via its dileucine motif to downregulate the CD4 receptor. Although these two Nef functions are related, the mechanisms governing SERINC5 downregulation are incompletely understood. Here, we demonstrate that two primary Nef isolates, referred to as 2410 and 2391 Nef, acquired from acutely HIV-1 infected women from Zimbabwe, both downregulate CD4 from the cell surface. However, only 2410 Nef retains the ability to downregulate cell surface SERINC5. Using a series of Nef chimeras, we mapped the region of 2391 Nef responsible for the functional uncoupling of these two antagonistic pathways to the dileucine motif. Modifications of the first and second ‘x’ positions of the 2410 Nef dileucine motif to asparagine and aspartic acid residues respectively (ND 164 ), impaired cell surface SERINC5 downregulation, which resulted in reduced infectious virus yield in the presence of SERINC5. The ND 164 mutation additionally partially impaired, but did not completely abrogate, Nef-mediated cell surface CD4 downregulation. Furthermore, the patient infected with HIV-1 encoding 2391 Nef had stable CD4 + T cell counts, whereas infection with HIV-1 encoding 2410 Nef resulted in CD4 + T cell decline and disease progression. Importance A contributing factor to HIV-1 persistence is evasion of the host immune response. HIV-1 uses the Nef accessory protein to evade the anti-viral roles of the adaptive and intrinsic innate immune responses. Nef targets SERINC5, a restriction factor which potently impairs HIV-1 infection by triggering SERINC5 removal from the cell surface. The molecular determinants underlying this Nef function remain incompletely understood. Recent studies have found a correlation between the extent of Nef-mediated SERINC5 downregulation and the rate of disease progression. Furthermore, single residue polymorphisms outside of the known Nef functional motifs can modulate SERINC5 downregulation. The identification of a naturally occurring Nef polymorphism impairing SERINC5 downregulation in this study supports a link between Nef downregulation of SERINC5 and the rate of plasma CD4 + T cell decline. Moreover, the observed functional impairments of this polymorphism could provide clues to further elucidate unknown aspects of the SERINC5 antagonistic pathway via Nef.


2005 ◽  
Vol 16 (5) ◽  
pp. 392-395 ◽  
Author(s):  
Catherine T Burton ◽  
Frances M Gotch ◽  
Nesrina Imami

Chemokine receptor genetic mutations are among the factors which have been shown to influence human susceptibility to HIV-1 infection and progression. The CCR2-64I mutation has been shown to delay HIV-1 disease progression in some studies. Here we show evidence of delayed disease progression, reflected in maintenance of a stable viral load and a slow CD4 T-cell decline, in a patient with the CCR2-64I gene. We then consider the potential value of identifying these genetic defects in the era of fusion/entry inhibiting therapeutics.


Virology ◽  
2018 ◽  
Vol 516 ◽  
pp. 21-29 ◽  
Author(s):  
Mingce Zhang ◽  
Tanya O. Robinson ◽  
Alexandra Duverger ◽  
Olaf Kutsch ◽  
Sonya L. Heath ◽  
...  

AIDS ◽  
2006 ◽  
Vol 20 (10) ◽  
pp. 1369-1377 ◽  
Author(s):  
Yea-Lih Lin ◽  
Clément Mettling ◽  
Pierre Portalès ◽  
Brigitte Réant ◽  
Véronique Robert-Hebmann ◽  
...  
Keyword(s):  
T Cell ◽  
Hiv 1 ◽  

2014 ◽  
Vol 10 (9) ◽  
pp. e1003830 ◽  
Author(s):  
Melissa M. Norström ◽  
Nazle M. Veras ◽  
Wei Huang ◽  
Mattia C. F. Proper ◽  
Jennifer Cook ◽  
...  

2006 ◽  
Vol 119 (1) ◽  
pp. 95-102 ◽  
Author(s):  
Uma Malhotra ◽  
Claire Huntsberry ◽  
Sarah Holte ◽  
Jean Lee ◽  
Lawrence Corey ◽  
...  

1989 ◽  
Vol 35 (8) ◽  
pp. 1746-1749 ◽  
Author(s):  
D Fuchs ◽  
T J Spira ◽  
A Hausen ◽  
G Reibnegger ◽  
E R Werner ◽  
...  

Abstract We assessed the value of urinary neopterin concentrations for prognosis of disease progression in HIV-1-infected patients. Sixty-eight anti-HIV-1 seropositive homosexuals with lymphadenopathy syndrome were tested for urinary neopterin and T-cell subset counts in 1982-83, and the incidence rate at which they developed acquired immunodeficiency syndrome (AIDS) between then and May 1988 was evaluated. Overall, 21 of 68 (30.9%) cases progressed to AIDS, with a yearly progression rate of 4-9%. The predictive value of urinary neopterin concentrations was higher (P = 0.0042) than that of CD4+ T-cell counts (P = 0.015) or the CD4+/CD8+ T-cell ratio (P = 0.022). Counts of CD8+ T-cells failed to show predictive significance (P = 0.29). Similarly, multivariate-regression analysis indicated that neopterin concentrations and CD4+ T-cell numbers were significant copredictors. Produced by human macrophages activated by interferon gamma, neopterin is thus a marker of macrophage activation via T cells. We conclude that these data demonstrate a correlation between the amount of T-cell-macrophage activation, as measured by urinary neopterin concentrations, and the progression of the disease.


Sign in / Sign up

Export Citation Format

Share Document